Hellenic Dynamics (HELD) Competitors GBX 0.95 0.00 (0.00%) (As of 11/1/2024) Add Compare Share Share Competitors Stock AnalysisChartCompetitors HELD vs. N4P, HLN, HIK, HCM, INDV, AMYT, AGY, APH, ANCR, and BXPShould you be buying Hellenic Dynamics stock or one of its competitors? The main competitors of Hellenic Dynamics include N4 Pharma (N4P), Haleon (HLN), Hikma Pharmaceuticals (HIK), HUTCHMED (HCM), Indivior (INDV), Amryt Pharma (AMYT), Allergy Therapeutics (AGY), Alliance Pharma (APH), Animalcare Group (ANCR), and Beximco Pharmaceuticals (BXP). These companies are all part of the "drug manufacturers - specialty & generic" industry. Hellenic Dynamics vs. N4 Pharma Haleon Hikma Pharmaceuticals HUTCHMED Indivior Amryt Pharma Allergy Therapeutics Alliance Pharma Animalcare Group Beximco Pharmaceuticals Hellenic Dynamics (LON:HELD) and N4 Pharma (LON:N4P) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, profitability, institutional ownership, dividends, analyst recommendations, valuation and community ranking. Is HELD or N4P more profitable? Hellenic Dynamics' return on equity of 0.00% beat N4 Pharma's return on equity.Company Net Margins Return on Equity Return on Assets Hellenic DynamicsN/A N/A N/A N4 Pharma N/A -82.39%-56.00% Does the media favor HELD or N4P? In the previous week, N4 Pharma's average media sentiment score of 0.00 beat Hellenic Dynamics' score of -0.99 indicating that N4 Pharma is being referred to more favorably in the news media. Company Overall Sentiment Hellenic Dynamics Negative N4 Pharma Neutral Which has stronger valuation and earnings, HELD or N4P? Hellenic Dynamics has higher earnings, but lower revenue than N4 Pharma. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHellenic DynamicsN/AN/AN/AN/AN/AN4 Pharma£23.52K121.67-£1.08MN/AN/A Do analysts recommend HELD or N4P? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hellenic Dynamics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/AN4 Pharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Do institutionals and insiders hold more shares of HELD or N4P? 0.1% of Hellenic Dynamics shares are held by institutional investors. 72.9% of Hellenic Dynamics shares are held by insiders. Comparatively, 18.0% of N4 Pharma shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Does the MarketBeat Community believe in HELD or N4P? N4 Pharma received 103 more outperform votes than Hellenic Dynamics when rated by MarketBeat users. CompanyUnderperformOutperformHellenic DynamicsN/AN/AN4 PharmaOutperform Votes10365.61% Underperform Votes5434.39% SummaryHellenic Dynamics beats N4 Pharma on 4 of the 7 factors compared between the two stocks. Ad Porter & CompanyWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. Get Hellenic Dynamics News Delivered to You Automatically Sign up to receive the latest news and ratings for HELD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HELD vs. The Competition Export to ExcelMetricHellenic DynamicsDrug Manufacturers IndustryMedical SectorLON ExchangeMarket Cap£1.40M£1.13B£5.09B£1.42BDividend YieldN/A3.13%7.46%11.92%P/E RatioN/A103.62133.021,596.48Price / SalesN/A2,857.471,686.23220,893.99Price / CashN/A10.0037.2227.13Price / BookN/A3.214.622.91Net IncomeN/A£141.80M£115.72M£157.91M7 Day PerformanceN/A0.70%-0.59%0.78%1 Month PerformanceN/A-1.05%5.80%-0.46%1 Year PerformanceN/A96.78%34.16%116.45% Hellenic Dynamics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HELDHellenic DynamicsN/AGBX 0.95flatN/A+2,367.5%£1.40MN/A0.00N/ANews CoverageN4PN4 PharmaN/AGBX 0.65+8.3%N/A-14.3%£2.57M£23,524.00-55.005Gap DownHigh Trading VolumeHLNHaleon0.9128 of 5 starsGBX 372.70-0.5%GBX 415+11.3%+16.0%£33.69B£11.26B3,105.8325,408High Trading VolumeHIKHikma Pharmaceuticals2.5452 of 5 starsGBX 1,903-0.9%GBX 2,325+22.2%+2.9%£4.22B£3.02B2,927.699,100HCMHUTCHMEDN/AGBX 291-4.6%N/A-10.3%£2.49B£610.81M-7,275.001,760Gap DownHigh Trading VolumeINDVIndivior2.1044 of 5 starsGBX 713.33+2.4%GBX 1,500+110.3%-55.1%£917.27M£1.15B-891.661,000Gap DownAMYTAmryt PharmaN/AGBX 143-11.7%N/A+0.0%£457.11M£210.24M-4.33290Gap DownAGYAllergy TherapeuticsN/AGBX 5.28-0.4%N/A+279.3%£251.86M£53.26M-88.00612APHAlliance Pharma2.6295 of 5 starsGBX 46.20+7.7%GBX 60+29.9%+18.0%£249.74M£183.15M-770.0091,000High Trading VolumeANCRAnimalcare GroupN/AGBX 232+3.6%N/A+36.2%£140.06M£76.10M2,900.00220High Trading VolumeBXPBeximco PharmaceuticalsN/AGBX 30.92+1.4%N/A-17.9%£137.95M£43.08B386.535,500 Related Companies and Tools Related Companies N4 Pharma Competitors Haleon Competitors Hikma Pharmaceuticals Competitors HUTCHMED Competitors Indivior Competitors Amryt Pharma Competitors Allergy Therapeutics Competitors Alliance Pharma Competitors Animalcare Group Competitors Beximco Pharmaceuticals Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:HELD) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Crypto 101 Media | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredThe Death Knell for U.S. StocksThey are among the 31 billionaires dumping their stocks at a record pace. Fortune calls this phenomenon "Th...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hellenic Dynamics Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Hellenic Dynamics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.